Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
doi: 10.3389/fendo.2019.00155 Received 04 December 2018 Accepted 21 February 2019 Published 12 April 2019 Volume 10 - 2019 Edited by Milka Vrecl, University of Ljubljana, Slovenia Reviewed by Jean Albert Boutin, Servier, France
First, as a spontaneous reporting system, the FAERS has inherent shortcomings, such as duplicate records with variable information quality
During the phase 3 trial of tirzepatide, 6.6% of patients discontinued the medication due to side effects [114]
No publicly verifiable patent documentation was identified at the time of this review to substantiate this claim, and it should be treated as the company's marketing positioning until independently confirmed
Combinations of these keywords were also used to ensure coverage of multiple relevant searches
Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: multi-target trial emulation study
US$ 29.58
US$ 28.92
US$ 28.49
US$ 24.32
US$ 21.12
US$ 22.25
US$ 23.37
US$ 23.67
US$ 20.25
